Etomidate

Especificaciones

33125-97-2Número CAS

251-385-9Número CE

ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylateNombre IUPAC

C14H16N2O2Fórmula química

244.29 g/molPeso molecular

Etomidate; 33125-97-2; Hypnomidate; Amidate; (+)-Etomidate; D-Etomidate; Etomidato; Etomidatum; ethyl 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylate; (+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate; R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate; R 16659; (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester; ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate; (R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester; NSC-759160; 1H-Imidazole-5-carboxylic acid, 1-[(1R)-1-phenylethyl]-, ethyl ester; CHEBI:4910; Z22628B598; 3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester; 1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester; DTXSID5023033; Ethomidate; Imidazole-5-carboxylic acid, 1-(alpha-methylbenzyl)-, ethyl ester, (R)-(+)-; ethyl 3-((1R)-1-phenylethyl)imidazole-4-carboxylate; ethyl 1-((1R)-1-phenylethyl)-1H-imidazole-5-carboxylate; Etomidate Injection; RefChem:56431; R26490; AMIDATE(TM) ETOMIDATE; ETOMIDATE injection, solution; N01AX07; DTXCID401765734; 251-385-9; (R)-ETHYL 1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLATE; Radenarcon; CHEMBL681; Amidate (pharmaceutical); ethyl (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylate; MFCD00869295; 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)- [CAS]; (d)-Etomidate; Etomidic acid; Etomidatum [INN-Latin]; Etomidato [INN-Spanish]; (R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic Acid Ethyl Ester; 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (+)-; SMR000466277; Amidate (TN); 1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester; Hypnomidate;; Amidate;; Etomidate CRS; Etomidate [USAN:USP:INN:BAN]; UNII-Z22628B598; R(+)-etomidate; V8D; EINECS 251-385-9; Etomidate; D-isomer; R-ETOMIDATE; BRN 0665833; Etomidate (USP/INN); ETOMIDATE [INN]; ETOMIDATE [MI]; ETOMIDATE [USAN]; 1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester; ETOMIDATE [VANDF]; ETOMIDATE [MART.]; ETOMIDATE [USP-RS]; ETOMIDATE [WHO-DD]; R-16659; SCHEMBL39487; MLS000758268; MLS001424163; GTPL5463; orb1225280; ETOMIDATE [ORANGE BOOK]; ETOMIDATE [EP MONOGRAPH]; ETOMIDATE [USP MONOGRAPH]; Etomidate 0.1 mg/ml in Methanol; Etomidate 1.0 mg/ml in Methanol; Imidazole-5-carboxylic acid, 1-(.alpha.-methylbenzyl)-, ethyl ester, (R)-(+)-; NPUKDXXFDDZOKR-LLVKDONJSA-N; 1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester; GLXC-07784; HMS2051P18; HMS2232A08; HMS3267N06; HMS3412D11; HMS3676D11; HY-B0100; Etomidate, >98% (HPLC), powder; BDBM50125935; EBC-06089; MSK163688; AKOS015920052; CCG-101054; CS-1833; DB00292; FE23198; GS-3208; NC00304; NSC 759160; NCGC00025176-01; 1-(1-Phenylethyl)-5-ethoxycarbonylimidazole; E0897; E7758; C07522; D00548; AB00639951_06; EN300-1074318; F079091; Q418445; SR-01000597569; SR-01000597569-1; BRD-K55055802-001-08-6; BRD-K55055802-001-09-4; BRD-K55055802-001-10-2; Z1741976844; 1-(1-Phenylethyl)imidazole-5-carboxylic acid ethyl ester; Etomidate, European Pharmacopoeia (EP) Reference Standard; r-(+)-ethyl-1-(1-phenylethyl)-1h-imidazole-5-carboxylate; Ethyl (R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylate; Etomidate, United States Pharmacopeia (USP) Reference Standard; (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylicacid ethyl esterSinónimos